M. (1993). Congestive heart failure: insights from epidemiology, impli- cations for treatment. Mayo Clinic Proceedings, 68, 1214-1218.Yamani, M. and Massie, B.M. (1993) Congestive Heart Failure: Insights from Epi- demiology, Implications for Treatment. Mayo Clinic Proceedings, 68, 1214-1218...
Congestive Heart Failure: Insights From Epidemiology, Implications for Treatment Chronic heart failure is a major cause of morbidity and mortality in the general population. Both, the increasing age of the population and success in the... Mohamad,Yamani,and,... - 《Mayo Clinic Proceedings》 被引...
et al. A Pilot Study on the Role of Autoantibody Targeting the beta 1-Adrenergic Receptor in the Response to beta-blocker Therapy for Congestive Heart Failure. Journal of cardiac failure 15, 224–232 (2009). Article CAS PubMed Google Scholar Wang, Y. et al. beta2 adrenergic receptor ...
HER2 therapy is not used for HER2 negative breast cancer. Side effects vary by drug given, but may include serious heart effects such as congestive heart failure, diarrhea, skin or liver toxicity. Herceptin (trastuzumab) is commonly used and has been shown to lower the chance for a recurrence...
It has been shown that in patients with congestive heart failure, baseline TTP is significantly prolonged, and after decongestive therapy, renal cortical TTP decreases but medullary TTP remains unchanged [91]. In a rat model of renal stasis, it was found that renal cortical PI was significantly...
Successful treatment of drug-resistant atrial tachycardia and intractable congestive heart failure with permanent coupled atrial pacing Temporary coupled atrial stimulation slowed the ventricular rate by nearly 50 percent in an adolescent patient with intractable congestive heart failure an... ER Arbel,HC ...
Mancia G Neurohumoral activation in congestive heart failure. Am Heart J. 1990;1201532- 1537Google ScholarCrossref 14. Leimbach WN JrWallin BGVictor RGAylward PESundlof GMark AL Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. ...
Congestive heart failure is a rare event in patients receiving imatinib therapy. Blood 2007; 110: 1233–1237. 68 Marcolino MS, Boersma E, Clementino NC, Nunes Mdo C, Barbosa MM, Silva MH et al. The duration of the use of imatinib mesylate is only weakly related to elevated BNP levels ...
Eplerenone is a specific MRA used to treat congestive HF and antihyperemia after acute myocardial infarction [146]. In one randomized, single-blind study, the combination eplerenone with ramipril was shown to reduce proteinuria in T2DKD [147]. Lindhardt et al. also confirmed that the addition...
Scientific Reports | 6:27410 | DOI: 10.1038/srep27410 2 www.nature.com/scientificreports/ Clinical characteristics Number of patients Age, mean (IQR) 64–74 years ≥75 years Female sex Congestive heart failure* Heart failure Left ventricular dysfunction Hypertension ...